Harmony Biosciences to Participate in Upcoming Investor Conferences
Harmony Biosciences (Nasdaq: HRMY) has announced its management team's upcoming participation in two major healthcare investor conferences in Miami, FL. The company will attend the Barclays Global Healthcare Conference on Tuesday, March 11, 2025, followed by the Leerink Partners Global Healthcare Conference on Wednesday, March 12, 2025.
At the Leerink conference, Harmony will participate in a fireside chat scheduled for 1:00 p.m. ET. Investors can access the webcast of this discussion through the investor relations section of Harmony's website at ir.harmonybiosciences.com.
Harmony Biosciences (Nasdaq: HRMY) ha annunciato la partecipazione del suo team di gestione a due importanti conferenze per investitori nel settore sanitario a Miami, FL. L'azienda parteciperà al Barclays Global Healthcare Conference martedì 11 marzo 2025, seguita dal Leerink Partners Global Healthcare Conference mercoledì 12 marzo 2025.
Durante la conferenza di Leerink, Harmony parteciperà a una chiacchierata informale programmata per le 13:00 ET. Gli investitori possono accedere alla diretta web di questa discussione attraverso la sezione relazioni con gli investitori del sito web di Harmony all'indirizzo ir.harmonybiosciences.com.
Harmony Biosciences (Nasdaq: HRMY) ha anunciado la próxima participación de su equipo de gestión en dos importantes conferencias para inversores en el sector de la salud en Miami, FL. La compañía asistirá a la Barclays Global Healthcare Conference el martes 11 de marzo de 2025, seguida de la Leerink Partners Global Healthcare Conference el miércoles 12 de marzo de 2025.
En la conferencia de Leerink, Harmony participará en una charla informal programada para la 1:00 p.m. ET. Los inversores pueden acceder a la transmisión en vivo de esta discusión a través de la sección de relaciones con inversores del sitio web de Harmony en ir.harmonybiosciences.com.
Harmony Biosciences (Nasdaq: HRMY)는 플로리다주 마이애미에서 열리는 두 개의 주요 건강 관리 투자자 회의에 경영진이 참석할 것이라고 발표했습니다. 이 회사는 2025년 3월 11일 화요일에 바클레이스 글로벌 헬스케어 컨퍼런스에 참석하고, 2025년 3월 12일 수요일에는 리어링크 파트너스 글로벌 헬스케어 컨퍼런스에 참석할 예정입니다.
리어링크 회의에서 Harmony는 오후 1시(ET)에 예정된 대화에 참여합니다. 투자자들은 Harmony 웹사이트의 투자자 관계 섹션(ir.harmonybiosciences.com)을 통해 이 토론의 웹캐스트에 접근할 수 있습니다.
Harmony Biosciences (Nasdaq: HRMY) a annoncé la participation prochaine de son équipe de direction à deux grandes conférences pour investisseurs dans le secteur de la santé à Miami, FL. L'entreprise assistera à la Barclays Global Healthcare Conference le mardi 11 mars 2025, suivie de la Leerink Partners Global Healthcare Conference le mercredi 12 mars 2025.
Lors de la conférence de Leerink, Harmony participera à une discussion informelle prévue à 13h00 ET. Les investisseurs peuvent accéder à la diffusion en direct de cette discussion via la section des relations avec les investisseurs du site Web de Harmony à l'adresse ir.harmonybiosciences.com.
Harmony Biosciences (Nasdaq: HRMY) hat die bevorstehende Teilnahme seines Management-Teams an zwei wichtigen Investorenkonferenzen im Gesundheitswesen in Miami, FL, angekündigt. Das Unternehmen wird am Dienstag, den 11. März 2025, an der Barclays Global Healthcare Conference teilnehmen, gefolgt von der Leerink Partners Global Healthcare Conference am Mittwoch, den 12. März 2025.
Auf der Leerink-Konferenz wird Harmony an einem informellen Gespräch teilnehmen, das für 13:00 Uhr ET geplant ist. Investoren können über den Bereich Investor Relations auf der Website von Harmony unter ir.harmonybiosciences.com auf die Übertragung dieser Diskussion zugreifen.
- None.
- None.
Barclays Global Healthcare Conference
-
Location:
Miami, FL - Tuesday, March 11, 2025
Leerink Partners Global Healthcare Conference
-
Location:
Miami, FL - Fireside Chat: Wednesday, March 12, 2025, at 1:00 p.m. ET
A webcast of the fireside chat will be available on the investor page of the Harmony Biosciences website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250304102783/en/
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
Source: Harmony Biosciences Holdings, Inc.
FAQ
When is Harmony Biosciences (HRMY) presenting at the Leerink Partners Conference in 2025?
Which investor conferences will HRMY attend in March 2025?
How can investors watch Harmony Biosciences' Leerink conference presentation?
Where are the HRMY investor conferences being held in March 2025?
